A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus

NCT02059564 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: HM11260C
DRUG: Placebo
DRUG: Victoza

Sponsor

Hanmi Pharmaceutical Company Limited